Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

with severe renal impairment (estimated creatinine clearance 15 ml/min to 30 ml/min) or established renal failure (estimated creatinine clearance less than 15 ml/min). See NICE's information on prescribing medicines. 1.3.13 Offer people with confirmed proximal DVT or PE and renal impairment (estimated creatinine clearance between 15 ml/min and 50 ml/min) one of: • apixaban • rivaroxaban • LMWH for at least 5 days followed by: － edoxaban or － dabigatran if estimated creatinine clearance is 30 ml/min or above • LMWH or UFH, given concurrently with a VKA for at least 5 days or until the INR is at least 2.0 in 2 consecutive readings, followed by a VKA on its own. Note the cautions and requirements for dose adjustment and monitoring in the medicine's SPC, and follow locally agreed protocols or advice from a specialist or multidisciplinary team. [2020] 1.3.14 Offer people with confirmed proximal DVT or PE and established renal failure (estimated creatinine clearance less than 15 ml/min) one of: • LMWH • UFH • LMWH or UFH concurrently with a VKA for at least 5 days or until the INR is at least 2.0 in 2 consecutive readings, followed by a VKA on its own. Note the
